RISK FACTORS OF VENOUS THROMBOEMBOLISM IN SUDANESE PREGNANT WOMEN
Abdalhabib EK, Alfeel A, Ali EI, Ibrahim IK, Mobarki AA, Dobie G, Hamali HA, Saboor M,
*Corresponding Author: Dr. Muhammad Saboor, Department of Medical Laboratory Technology, Faculty of Applied Medical Science, Jazan University, Jazan, Saudi Arabia. Tel.: +966-54-495-9029. E-mail: msaboor@ jazanu.edu.sa
page: 49

REFERENCES

1. Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017; 359: j4452. 2. Seligsohn U, Lubetsky A. Medical progress: Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16): 1222-1231. 3. Roozbeh N, Banihashemi F, Mehraban M, Abdi F. Potential role of Factor V Leiden mutation in adverse pregnancy outcomes: An updated systematic review. Biomed Res Ther. 2017; 4(12): 1832-1846. 4. Cernera G, Di Minno A, Amato F, Elce A, Liguori R, Bruzzese D, et al. Molecular analysis of prothrom botic gene variants in venous thrombosis: A potential role for sex and thrombotic localization. J Clin Med. 2020; 9(4): 1008. 5. Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar A, Al Kharusi L, et al. Venous thromboembolism risk and adequacy of prophylaxis in high risk pregnancy in the Arabian Gulf. Curr Vasc Pharmacol. 2016; 14(4): 368-373. 6. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194(5): 1311-1315. 7. Ormesher L, Simcox L, Tower C, Greer IA. Management of inherited thrombophilia in pregnancy. Womens Health (Lond). 2016; 12(4): 433-441. 8. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, et al. Risk of pregnancy- associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005; 3(5): 949-954. 9. Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002; 167(1): 48-54. 10. Elzein HO, Saad AA, Yousif AA, Elamin E, Abdalhabib EK, Elzaki SEG. Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia. Curr Res Transl Med. 2020; 68(2): 77-80. 11. Hoffbrand AV, Moss PAH, Editors. Platelets, blood coagulation and haemostasis. Hoffbrand’s Essential Hematology, 7th ed. Chichester, West Sussex, UK: John Wiley & Sons, Ltd. 2016: 135-144. 12. Kujovich JL. Factor v Leiden thrombophilia. Genet Med. 2011; 13(1): 1-16. 13. Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy: A populationbased cohort study from the United Kingdom. Blood. 2013; 121(19): 3953-3961. 14. Barillari G, Londero AP, Brenner B, Nauffal D, Muñoz-Torrero JFS, Del Molino F, et al.; RIETE Registry. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry. Eur J Intern Med. 2016; 32: 53-59. 15. Knight M, UKOSS Antenatal pulmonary embolism: Risk factors, management and outcomes. BJOG. 2008; 115(4): 453-461. 16. Gader AA, Haggaz AED, Adam I. Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag. 2009; 5(1): 85-87. 17. Babker AM, Ahmed IAM, Ismail M, Hassan FM, Osman AL, Kandakurti PK, et al. Lack of association between Factor V Leiden G1691A, prothrombin G20210A, MTHFC677T mutations, and early recurrent pregnancy loss in a group of Sudanese women. Open Access Maced J Med Sci. [Internet]. 2020; 8(B): 553-557. 18. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study. QJM. 2006; 99(5): 289-298. 19. Elgari MM, Ibrahim NA, Muddathir ARM, Eltoom FM, Ibrahim IM. Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sci. 2017; 12(1): 162-166. 20. Ahmed NA, Adam I, Elzaki SEG, Awooda HA, Hamdan HZ. Factor V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with pre-eclampsia, a case-control study. BMC Med Genet. 2019; 20(1): 16-20. 21. Curigliano G, Mandalà M, Sbanotto A, Colleoni M, Ferretti G, Bucciarelli P, et al. Factor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis. Support Cancer Ther [Internet]. 2006; 3(2): 98-102. 22. Monsuez J-J, Bouali H, Serve E, Boissonnas A, Alhenc- Gelas M. Deep venous thrombosis associated with Factor V Leiden, G20210A mutation, and protein S deficiency. Am J Med. 2003; 114(5): 421-422. 23. Franchini M. Utility of testing for factor V Leiden. Blood Transfus. 2012; 10(3): 257-259. 24. Farajzadeh M, Bargahi N, Poursadegh Zonouzi A, Farajzadeh D, Pouladi N. Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population. Meta Gene [Internet]. 2014; 2: 505–13. 25. Jusić-Karić A, Terzić R, Jerkić Z, Avdić A, Podanin M. Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet. 2016; 19(1): 43-49.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006